Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
Clin Appl Thromb Hemost
; 6(4): 187-9, 2000 Oct.
Article
em En
| MEDLINE
| ID: mdl-11030522
ABSTRACT
There is no consensus concerning thromboembolic prophylaxis in high-risk pregnant women with a previous history of heparin-induced thrombocytopenia. An alternative anticoagulant therapy is danaparoïd, whereas unfractioned and low-molecular-weight heparin therapy is contraindicated. We report a case of successful thrombosis prophylaxis using danaparoïd in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia during a previous pregnancy and Widal's disease.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Complicações Hematológicas na Gravidez
/
Tromboembolia
/
Sulfatos de Condroitina
/
Dermatan Sulfato
/
Heparitina Sulfato
Idioma:
En
Ano de publicação:
2000
Tipo de documento:
Article